Related Experiment Video
Updated: Jun 27, 2026
12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
[Pelvic lymph node dissection (extended vs standard) and prostate cancer].
A Rincón Mayans1, J J Zudaire Bergera, J Rioja Zuazu
1Departamento de Urología, Clínica Universitaria de Navarra, Pamplona. arincon@unav.es
Actas Urologicas Espanolas
|December 3, 2008
Summary
Pelvic lymphadenectomy (PLND) in prostate cancer aids staging but its extent and patient selection remain debated. This review evaluates current evidence on lymph node dissection in prostate cancer management.
Area of Science:
- Urology
- Oncology
- Surgical Pathology
Background:
- Pelvic lymphadenectomy (PLND) in prostate cancer is crucial for accurate staging.
- PLND guides postoperative adjuvant treatment decisions.
- The optimal extent and patient selection for PLND are debated.
Purpose of the Study:
- To critically evaluate the current evidence regarding lymph node dissection in prostate cancer.
- To clarify the role and benefits of PLND in prostate cancer management.
Main Methods:
- Literature review of current studies on pelvic lymphadenectomy in prostate cancer.
- Analysis of data concerning limited vs. extended PLND.
- Evaluation of criteria for selecting patients for PLND.
Main Results:
- PLND is the established method for histological staging in prostate cancer.
- Debate persists regarding the optimal extent of dissection (limited vs. extended).
- Identifying the ideal candidates for PLND remains an active area of research.
Conclusions:
- Pelvic lymphadenectomy provides essential staging information for prostate cancer.
- Further research is needed to define the optimal extent and patient selection for PLND.
- Standardizing PLND protocols may improve treatment outcomes.